期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

感染生物标志物的临床应用价值 被引量：4

Clinical value of sepsis biomarkers
原文传递
导出
摘要 脓毒症在重症监护室患者中的发病率高,是最重要的致死性病因之一,但缺乏特异性临床表现。文章介绍了对脓毒症诊断、预后判断具有临床价值的分子标志物,以及未来的发展方向。 Sepsis is the most important cause of morbidity and mortality in the intensive care unit （ICU） , but it lacks specif- ic clinical manifestations. In this article, the author introduced the vaulable biomarkers on sepsis diagnosis, predicting severi- ty and prognosis, and highlighted the direction of sepsis biomarkers research.
作者 解立新
机构地区 解放军总医院呼吸科
出处 《中国实用内科杂志》 CAS CSCD 北大核心 2014年第2期177-179,共3页 Chinese Journal of Practical Internal Medicine
基金 国家科技支撑计划(2009BAI86B03)
关键词 脓毒症 生物学标记物 肺炎 sepsis biomarker pneumonia
分类号 R446.1 [医药卫生—诊断学]
  • 相关文献

参考文献22

  • 1Cheng CW, Chien MH, Su SC, et al. New markers in pneumonia [ J]. Clin Chim Acta,2013,419 : 19 - 25.
  • 2张婷,陈烨,王中秋,周有连,张绍衡,王浦,谢珊,姜泊.炎症性肠病患者肠道菌群结构的变化及其与炎性指标的关系[J].南方医科大学学报,2013,33(10):1474-1477. 被引量：51
  • 3严静,饶群.生物标志物在急性呼吸窘迫综合征诊断及预后评估的作用[J].中国实用内科杂志,2013,33(11):840-843. 被引量：9
  • 4解立新.脓毒症:新兴生物学分子标志物初探(英文)[J].解放军医学杂志,2013,38(1):6-9. 被引量：9
  • 5Pien'akos C, Vincent JL. Sepsis biomarkers :a review [ J ]. Crit Care, 2010,14(1) :R15.
  • 6Vincent JL, Beumier M. Diagnostic and prognostic markers in sepsis [ J 1. Expert Rev Anti Infect Ther,2013,11 ( 3 ) :265 - 275.
  • 7Limper M, de Kruif MD, Dttits A J, et al. Tile diagnostic role of pro- ealeitonin and other biomarkers in diseriminating infectious from non-infectious fever[ J ]. J Infect ,2010,60 (6) :409 - 416.
  • 8Herzum I, Renz H. Inflammatory markers in SIRS, sepsis and septic shock[ Jl. Curr Med Chem,2008,15(6) :581 -587.
  • 9Su L, Feng L, Song Q, et al. Diagnostie value of dynamics serum sCD163, sTREM-1, PCT, and CRP in differentiating sepsis, severity assessment, and prognostic prediction [ J ]. Mediat Inflamm, 2013 :969875.
  • 10Sehuetz P,Amin DN,Greenwald JL. Role of proealcitonin in man- aging adult patients with respiratory tract infections ： J ]. Chest, 2012,141 (4) :1063 - 1073.

二级参考文献36

  • 1余颖聪,姒健敏,樊宇靖,陈淑洁.肠易激综合征患者肠道微生态对照研究[J].中华消化杂志,2004,24(7):427-427. 被引量：60
  • 2欧阳钦,胡品津,钱家鸣,郑家驹,胡仁伟.对我国炎症性肠病诊断治疗规范的共识意见[J].胃肠病学,2007,12(8):488-495. 被引量：751
  • 3Lesur O, Langevin S, Berthiaume Y, et al. Outcome value of Clara cell protein in serum of patients with acute respiratory distress syn- drome[ J]. Intensive Care Med ,2006,32 : 1167 - 1174.
  • 4Determann RM, Millo JL,Waddy S, et al. Plasma CC16 levels are associated with development of ALI/ARDS in patients with ventila- tor-associated pneumonia : a retrospective observational study [ J ]. BMC Pulmonary Medicine,2009(9) :49 -58.
  • 5Determann RM, Royakkers A, Lutter. Clara R. Cell Protein and Sur- factant Protein D Plasma Levels are Associated with Clinical Out- comes of Mechanically Ventilated Patients[J]. J Pulmon Resp Med, 2013,3 : 138 - 142.
  • 6Determann RM,Royakkers AANM. Plasma levels of surfactant pro- tein D and KL-6 for evaluation of lung injury in critically ill me- chanically ventilated patients [ J ]. BMC Pulmonary Medicine,2010, 10:6.
  • 7Kuzovlev A, Moroz V, Goloubev A. Polovnikov. Biomarkers for early stage of acute respiratory distress syndrome in septic patients : surfac- tant protein D and Clara cell protein[J]. Critical Care, 2013,17 ( Suppl 2 ) : 100.
  • 8Kurdowska A, Noble JM, Grant IS, et al. Anti-interleukin-8 autoanti- biodies in patients at respiratorydistress syndrome [J]. Crit Med,2002,30(10):2335 -2337.
  • 9Meduri GU, Headley S, Kohler G, et al. Persistent elevation of in- flammatory cytokines predicts a poor outcome in ARDS:plasma IL- 1β and IL-6 are consistent and efficient predictors of outcome over- time[J]. Chest, 1995,107 : 1062 - 1073.
  • 10Donnelly SC,Stricter RM, Kunkel SL,et al. Interleukin-8 and devel- opment of adult respiratory distress syndromcin at-risk patients [ J ]. Lancet, 1993,341:643 - 647.

共引文献66

同被引文献30

  • 1Dellinger RP, Levy MM, Rhodes A, et al. Surviving sepsis campaign: international guidelines for management of severesepsis and septic shock: 2012 [J]. Crit Care Med, 2013, 41(2) : 580-637.
  • 2Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis [J]. Chest, 1992, 101(6): 1644-1655.
  • 3Badolato R, Wang JM, Stornello SL, et al. Serum amyloid is an activator of PMN antimicrobial functions: induction of degranulation, phagocytosis, and enhancement of anti- Candida activity [J]. J Leukoc Biol, 2000, 67(3): 381- 386.
  • 4Lee HY, Kim SD, Shim JW, et al. Acitvation of formyl peptide receptor like-1 by serum amyloid A induces CCL2 production in human umbilical vein endothelial cells [J]. Bioehem Biophys Res Commun, 2009, 380(2): 313-317.
  • 5Mullan RH, Bresnihan B, Golden-Mason L, et 8,1. Acute- phase serum amyloid A stimulation of angiogenesis, leukocyte recruitment, and matrix degradation in rheumatoid arthritis thROUGH an NF-kappaB-dependent signal transduction pathway [ J ]. Arthritis Rheum, 2006, 54 ( 1 ) : 105-114.
  • 6Cetinkaya M, Ozkan H, Koksal N, et al. Comparison of serum amyloid A concentrations with those of C-reactive protein and procalcitonin in diagnosis and follow-up of neonatal sepsis in premature infants. [J]. J Perinatol, 2009, 29(3) : 225-231.
  • 7Yuan H, Huang J, Lv B, et al. Diagnosis value of the serum amyloid A test in neonatal sepsis:a meta-analysis [J]. Biomed Res Int, 2013:520294.
  • 8Chan T, Gu F. Early diagnosis of sepsis using serum biomarkers [J]. Expert Rev Mol Diagn, 2011, 11(5): 487- 496.
  • 9Enguix A1, Rey C, Concha A, et al. Comparison of proea/eitonin with C-reactive protein and serum amyloid for the early diagnosis of bacterial sepsis in critically ill neonates and children [J]. Intensive Care Med, 2001, 27(1): 211- 215.
  • 10Davison DL,Terek M,Chawla LS.Neurogenic pulmonary edema[J].Critical Care,2012,16(2):212.

引证文献4

二级引证文献13

中国实用内科杂志
2014年 第2期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部